Cartesian Therapeutics, Inc. Equity Securities without Readily Determinable Fair Value, Amount
Cartesian Therapeutics, Inc. (RNAC) had Equity Securities without Readily Determinable Fair Value, Amount of $0 as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2026-03-09
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Amount $0.00.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Amount $2.00M.
- 2025-06-30: Equity Securities without Readily Determinable Fair Value, Amount $2.00M.
- 2025-03-31: Equity Securities without Readily Determinable Fair Value, Amount $2.00M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.00M 10-K · filed 2026-03-09 |
| 2024-09-30 | $2.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.00M 10-K · filed 2025-03-13 |
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $2.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $2.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-02 |
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |